AzTrials
AzTrials

Inguinal HerniaNCT03450811

Effect of Inguinal Hernia Repair on Uroflowmetric Parameteres

A study testing Inguinal hernia repair in people with Inguinal Hernia and Urinary Retention, run by Ankara Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Post operative acute urinary retension or voiding dysfunction are complications after inguinal hernia repair and they cause a great deal of discomfort and stress to patients. Furthermore, they can also increase hospital costs by increasing hospital stay, and by growing the need for outpatient appointments after an… Read more about this study

Who is it for?
Ages 20 to 90 years, men onlyHealthy volunteers can take part
What is being tested?
Inguinal hernia repair
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2018to 1 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 90 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • any type of inguinal hernia

Who cannot join

  • active urinary tract infection,
  • previous BPH, neurological disease or significant systemic disease,
  • medications that could interfere voiding function
  • history of prostate, bladder or urethral surgery or traumatic urethral catheterisation.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara Training and Research Hospital

    Ankara, 06340

Other trials in Turkey (Türkiye)

About this study

Official title: Does the Inguinal Hernia Repair Affect Uroflowmetric Values? A Prospective Controlled Clinical Trial.

Post operative acute urinary retension or voiding dysfunction are complications after inguinal hernia repair and they cause a great deal of discomfort and stress to patients. Furthermore, they can also increase hospital costs by increasing hospital stay, and by growing the need for outpatient appointments after an elective surgical procedure. Some studies recommend prophylactic alpha blockers to minimizing these adverse effects.

Investigators aimed to determine the changes of uroflowmetric values for male patients following elective inguinal hernia repair.

Read the detailed description

Inguinal hernia repair is a common procedure performed in general surgery, with an annual rate of 28 per 100,000 of the population in the USA. The incidence of post operative inability voiding in males following open or laparoscopic inguinal hernia repair varies from 3 to 25%. Evaluating risk factors to reduce the occurence of this complications after one of the most commonly performed surgery by general surgeons could help reduce that high rate of that complication. Although some authors recommend prophylactic alpha blockers, there is no consensus on whether these can decrease rate of urinary retention or voiding dysfunction in male patients.

In current study, investigators aimed to determinate the uroflowmetric parametric changes of patients after elective inguinal hernia repair.

Being tested
Inguinal hernia repair
Keywords
complication, uroflowmetry
Medical subject headings
Hernia, Inguinal, Urinary Retention, Lower Urinary Tract Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inguinal hernia repairProcedure or surgery

    Lichtenstein procedure or laparoscopic method (Total extraperitoneal) inguinal hernia repair

Study groups in NCT03450811
Study groupRoleWhat they receive
Study groupActive comparatorThe patients underwent elective open or laparoscopic inguinal hernia repair at a general surgery clinic.
Receives: Procedure: Inguinal hernia repair
Control groupNo interventionpatients who were admitted to the outpatient clinics with various diseases or healthy persons

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with undergoes inguinal hernia repair -related voiding dysfunction as assessed by uroflowmetry

    Maximum and average flow rate (ml/sn) were determinated on post-operative day 1

    Measured: 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Mar 2018
  2. Study start1 Jan 2018
  3. Primary completion20 Feb 2018
  4. Study completion1 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The patients who underwent elective open or laparoscopic inguinal hernia repair were treated by a single general surgeon.
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03450811
Sponsor's protocol ID
317
Status last verified
Mar 2018
First submitted
19 Feb 2018
Last updated
27 Mar 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Mohammadi-Fallah M, Hamedanchi S, Tayyebi-Azar A. Preventive effect of tamsulosin on postoperative urinary retention. Korean J Urol. 2012 Jun;53(6):419-23. doi: 10.4111/kju.2012.53.6.419. Epub 2012 Jun 19.

    PubMed 22741052
  • Clancy C, Coffey JC, O'Riordain MG, Burke JP. A meta-analysis of the efficacy of prophylactic alpha-blockade for the prevention of urinary retention following primary unilateral inguinal hernia repair. Am J Surg. 2018 Aug;216(2):337-341. doi: 10.1016/j.amjsurg.2017.02.017. Epub 2017 Mar 14.

    PubMed 28341140

Questions about this trial

What is this clinical trial studying?

A study testing Inguinal hernia repair in people with Inguinal Hernia and Urinary Retention, run by Ankara Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with undergoes inguinal hernia repair -related voiding dysfunction as assessed by uroflowmetry (time frame: 3 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03450811, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in